These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6149687)

  • 41. [SYNCOPE CAUSED BY INTRA-OCULAR TIMOLOL].
    Eyal A; Braun E; Naffaa ME
    Harefuah; 2015 Nov; 154(11):701-2, 742. PubMed ID: 26821501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allergic contact dermatitis due to the beta-blocker betaxolol in eyedrops, with cross-sensitivity to timolol.
    Nino M; Napolitano M; Scalvenzi M
    Contact Dermatitis; 2010 May; 62(5):319-20. PubMed ID: 20536484
    [No Abstract]   [Full Text] [Related]  

  • 44. Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
    Patane' S; Marte F; Di Bella G; Pugliatti P
    Int J Cardiol; 2008 Jun; 126(3):e43-6. PubMed ID: 17418438
    [No Abstract]   [Full Text] [Related]  

  • 45. Alopecia Induced by Timolol Eye-drops.
    Muramatsu K; Nomura T; Shiiya C; Nishiura K; Tsukinaga I
    Acta Derm Venereol; 2017 Feb; 97(2):295-296. PubMed ID: 27545615
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum lipid profile and timolol gel.
    Khamar MB; Bhatt N; Patel K
    J Indian Med Assoc; 2002 Oct; 100(10):620-1. PubMed ID: 12452518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma.
    Dickstein K; Hapnes R; Aarsland T
    Am J Ophthalmol; 2001 Nov; 132(5):626-32. PubMed ID: 11704023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical effectiveness and mechanism of action of thymoptic in glaucoma].
    Shmyreva VF; Fridman NV; Makashova NV
    Vestn Oftalmol; 1982; (3):8-10. PubMed ID: 6126027
    [No Abstract]   [Full Text] [Related]  

  • 49. Eye drops and lethargy.
    Vahidassr MD; Foy CJ; O'Malley T; Passmore AP
    J R Soc Med; 1997 Mar; 90(3):155. PubMed ID: 9135614
    [No Abstract]   [Full Text] [Related]  

  • 50. Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma.
    DuBiner HB; Hill R; Kaufman H; Keates EU; Zimmerman TJ; Mandell AI; Mundorf TK; Bahr RL; Schwartz LW; Towey AW; Hurvitz LM; Starita RJ; Sassani JW; Ropo A; Gunn R; Stewart WC
    Am J Ophthalmol; 1996 May; 121(5):522-8. PubMed ID: 8610795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
    Stewart WC; Dubiner HB; Mundorf TK; Laibovitz RA; Sall KN; Katz LJ; Singh K; Shulman DG; Siegel LI; Hudgins AC; Nussbaum L; Apostolaros M
    Am J Ophthalmol; 1999 Feb; 127(2):142-7. PubMed ID: 10030554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological therapy for glaucoma: a review.
    Hoyng PF; van Beek LM
    Drugs; 2000 Mar; 59(3):411-34. PubMed ID: 10776828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-adrenoceptor blocking drugs and the glaucoma suspect.
    Langham ME
    Ann Ophthalmol; 1981 Mar; 13(3):273. PubMed ID: 6114701
    [No Abstract]   [Full Text] [Related]  

  • 54. Sinoatrial block induced by timolol eyedrops.
    Calenda E; Tourrel F
    Can J Ophthalmol; 2007 Feb; 42(1):149. PubMed ID: 17361266
    [No Abstract]   [Full Text] [Related]  

  • 55. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
    Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
    Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
    Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
    Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pressure or progression?
    Burnstein Y; Robin AL
    Arch Ophthalmol; 1999 Mar; 117(3):417-9. PubMed ID: 10088833
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A new beta-blocking agent in the treatment of chronic glaucoma: timolol maleate].
    Demailly P; Lehner MA; Duperré J
    Bull Soc Ophtalmol Fr; 1976; 76(9-10):801-2. PubMed ID: 19158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.